Omnicare Subsidiaries Offers IPF Patient Support Services for Ofev
Two subsidiaries of Omnicare Specialty Care Group (SCG) recently announced they have been chosen to provide services to idiopathic pulmonary fibrosis (IPF) patients taking OFEV® (nintedanib), a recently-approved tyrosine kinase inhibitor developed by Boehringer Ingelheim. RxCrossroads and Advanced Care Scripts (ACS) have been selected to carry out reimbursement…